Found: 7
Select item for more details and to access through your institution.
Perampanel-associated self-harm ideation after dosage increase.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 8, p. 1009, doi. 10.1007/s00228-017-2254-y
- By:
- Publication type:
- Article
Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 7, p. 1103, doi. 10.1007/s00228-012-1232-7
- By:
- Publication type:
- Article
Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".
- Published in:
- 2017
- By:
- Publication type:
- letter
Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012.
- Published in:
- Allergy, 2018, v. 73, n. 11, p. 2224, doi. 10.1111/all.13456
- By:
- Publication type:
- Article
Desensitization protocol for angio‐oedema induced by encorafenib in a patient with metastatic melanoma.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 7, p. e271, doi. 10.1111/jdv.15544
- By:
- Publication type:
- Article
Beta‐lactam‐induced severe neutropaenia: a descriptive study.
- Published in:
- Fundamental & Clinical Pharmacology, 2019, v. 33, n. 2, p. 225, doi. 10.1111/fcp.12419
- By:
- Publication type:
- Article